Suppr超能文献

新生儿败血症:特别是关于头孢噻肟使用的重新评估

Neonatal septicemia: a reappraisal with special reference to the use of cefotaxime.

作者信息

Vaidya U, Bhave S, Hegde V, Pandit A N

机构信息

Department of Pediatrics, K.E.M. Hospital, Pune.

出版信息

Indian Pediatr. 1991 Nov;28(11):1265-70.

PMID:1808046
Abstract

In a study period of one year, 381 babies (38.7% of all nursery admissions) were clinically diagnosed to have sepsis. Of these, 156 (40.9%) had positive blood cultures. Klebsiella was by far the commonest organism isolated (41%) followed by other Gram negative organisms. Gram positive organisms were uncommon (8%). Sensitivity of Gram negative organisms was poor to penicillin (11%) and ampicillin (18%); significantly better to kanamycin (65%), gentamicin (74%) and best to cefotaxime (79%). Only 8% isolates were resistant to all antibiotics. Combination of cefotaxime and gentamicin was effective against 90% of the isolates (in vitro) as compared to 74% for gentamicin and ampicillin. In vivo, mortality in the cefotaxime treated group was significantly lower (24.3%) than control group (47%) although both groups were clinically and bacteriologically comparable (p less than 0.05).

摘要

在为期一年的研究期间,381名婴儿(占所有新生儿病房收治病例的38.7%)被临床诊断为患有败血症。其中,156名(40.9%)血培养呈阳性。迄今为止,分离出的最常见病原体是克雷伯菌(41%),其次是其他革兰氏阴性菌。革兰氏阳性菌不常见(8%)。革兰氏阴性菌对青霉素(11%)和氨苄青霉素(18%)的敏感性较差;对卡那霉素(65%)、庆大霉素(74%)敏感性显著更好,对头孢噻肟(79%)敏感性最佳。仅8%的分离株对所有抗生素耐药。与庆大霉素和氨苄青霉素对74%的分离株有效(体外)相比,头孢噻肟和庆大霉素联合用药对90%的分离株有效(体外)。在体内,头孢噻肟治疗组的死亡率(24.3%)显著低于对照组(47%),尽管两组在临床和细菌学方面具有可比性(p小于0.05)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验